On January 1, 2020, WellDyneRx will update the Open Access and Clinical Focus formularies with several changes, summarized in the tables linked below:
Letters were mailed to affected members in October that outlined the changes and listed formulary alternatives. Click the links below to view copies of the member letters.
To learn more, please contact your Account Executive.
2019 Quarter Four WellInformed Table Contents
- WellConnect Secure Text Messages Enhance Patient Engagement
- Formulary Updates
- Affordable Care Act FAQ 40 Regarding HHS Notice of Benefit and Payment Parameters for 2020
- WellDyneRx Fights to Bring Light to the Darkness of Cancer
- Upcoming Tradeshows, Conferences & Events
- Upcoming Healthcare Observances
- FDA Approval List